Related Experiment Videos
Antireflux surgery for Barrett's oesophagus
1Department of Surgery, University of Southern California Keck School of Medicine, Los Angeles, California 90089, USA. rlord@hsc.usc.edu
ANZ Journal of Surgery
|March 29, 2003
Summary
Antireflux surgery effectively controls reflux symptoms and reduces duodenal reflux in Barrett's esophagus patients. However, it does not prevent dysplasia or cancer, necessitating continued surveillance.
Area of Science:
- Gastroenterology
- Surgical Oncology
Background:
- Barrett's esophagus is a complication of severe gastroesophageal reflux disease (GERD).
- Management focuses on symptom relief for patients without high-grade dysplasia.
Purpose of the Study:
- To evaluate the efficacy of antireflux surgery in managing Barrett's esophagus.
- To assess the impact of surgery on reflux symptoms, esophageal acid exposure, and duodenal reflux.
Main Methods:
- Review of medium-term follow-up studies (2-5 years) on antireflux surgery outcomes.
- Comparison of antireflux surgery with medical therapy for reflux management.
- Analysis of data regarding the prevention of dysplasia and cancer development.
Main Results:
- Antireflux surgery provides excellent symptom control in over 90% of patients.
- Surgery normalizes esophageal acid exposure and reduces duodenal nonacid reflux.
- No conclusive evidence shows surgery prevents dysplasia or induces regression.
Conclusions:
- Antireflux surgery is effective for symptom control and reducing reflux in Barrett's esophagus.
- Patients require ongoing surveillance for dysplasia and cancer post-surgery.
- Combination therapy (surgery + ablation) shows promise for low-grade dysplasia.